Literature DB >> 17251353

Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1.

Zakir Hossain1, Safiah Mohamed Ali, Hui Ling Ko, Jianliang Xu, Chee Peng Ng, Ke Guo, Zeng Qi, Sathivel Ponniah, Wanjin Hong, Walter Hunziker.   

Abstract

Wwtr1 is a widely expressed 14-3-3-binding protein that regulates the activity of several transcription factors involved in development and disease. To elucidate the physiological role of Wwtr1, we generated Wwtr1-/- mice by homologous recombination. Surprisingly, although Wwtr1 is known to regulate the activity of Cbfa1, a transcription factor important for bone development, Wwtr1-/- mice show only minor skeletal defects. However, Wwtr1-/- animals present with renal cysts that lead to end-stage renal disease. Cysts predominantly originate from the dilation of Bowman's spaces and atrophy of glomerular tufts, reminiscent of glomerulocystic kidney disease in humans. A smaller fraction of cysts is derived from tubules, in particular the collecting duct (CD). The corticomedullary accumulation of cysts also shows similarities with nephronophthisis. Cells lining the cysts carry fewer and shorter cilia and the expression of several genes associated with glomerulocystic kidney disease (Ofd1 and Tsc1) or encoding proteins involved in cilia structure and/or function (Tg737, Kif3a, and Dctn5) is decreased in Wwtr1-/- kidneys. The loss of cilia integrity and the down-regulation of Dctn5, Kif3a, Pkhd1 and Ofd1 mRNA expression can be recapitulated in a renal CD epithelial cell line, mIMCD3, by reducing Wwtr1 protein levels using siRNA. Thus, Wwtr1 is critical for the integrity of renal cilia and its absence in mice leads to the development of renal cysts, indicating that Wwtr1 may represent a candidate gene for polycystic kidney disease in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17251353      PMCID: PMC1785239          DOI: 10.1073/pnas.0605266104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Z/AP, a double reporter for cre-mediated recombination.

Authors:  C G Lobe; K E Koop; W Kreppner; H Lomeli; M Gertsenstein; A Nagy
Journal:  Dev Biol       Date:  1999-04-15       Impact factor: 3.582

2.  Cooperative interactions between activating transcription factor 4 and Runx2/Cbfa1 stimulate osteoblast-specific osteocalcin gene expression.

Authors:  Guozhi Xiao; Di Jiang; Chunxi Ge; Zhuoran Zhao; Yumei Lai; Heidi Boules; Mattabhorn Phimphilai; Xiangli Yang; Gerard Karsenty; Renny T Franceschi
Journal:  J Biol Chem       Date:  2005-07-05       Impact factor: 5.157

Review 3.  Cleidocranial dysplasia: clinical and molecular genetics.

Authors:  S Mundlos
Journal:  J Med Genet       Date:  1999-03       Impact factor: 6.318

4.  TAZ, a transcriptional modulator of mesenchymal stem cell differentiation.

Authors:  Jeong-Ho Hong; Eun Sook Hwang; Michael T McManus; Adam Amsterdam; Yu Tian; Ralitsa Kalmukova; Elisabetta Mueller; Thomas Benjamin; Bruce M Spiegelman; Phillip A Sharp; Nancy Hopkins; Michael B Yaffe
Journal:  Science       Date:  2005-08-12       Impact factor: 47.728

5.  TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins.

Authors:  F Kanai; P A Marignani; D Sarbassova; R Yagi; R A Hall; M Donowitz; A Hisaminato; T Fujiwara; Y Ito; L C Cantley; M B Yaffe
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

6.  Oral-facial-digital syndrome type 1 is another dominant polycystic kidney disease: clinical, radiological and histopathological features of a new kindred.

Authors:  S A Feather; P J Winyard; S Dodd; A S Woolf
Journal:  Nephrol Dial Transplant       Date:  1997-07       Impact factor: 5.992

7.  Mutations in the hepatocyte nuclear factor-1beta gene are associated with familial hypoplastic glomerulocystic kidney disease.

Authors:  C Bingham; M P Bulman; S Ellard; L I Allen; G W Lipkin; W G Hoff; A S Woolf; G Rizzoni; G Novelli; A J Nicholls; A T Hattersley
Journal:  Am J Hum Genet       Date:  2000-11-20       Impact factor: 11.025

8.  The Oak Ridge Polycystic Kidney (orpk) disease gene is required for left-right axis determination.

Authors:  N S Murcia; W G Richards; B K Yoder; M L Mucenski; J R Dunlap; R P Woychik
Journal:  Development       Date:  2000-06       Impact factor: 6.868

9.  Oral-facial-digital type I protein is required for primary cilia formation and left-right axis specification.

Authors:  Maria Immacolata Ferrante; Alessandro Zullo; Adriano Barra; Sabrina Bimonte; Nadia Messaddeq; Michèle Studer; Pascal Dollé; Brunella Franco
Journal:  Nat Genet       Date:  2005-11-27       Impact factor: 38.330

10.  Chlamydomonas IFT88 and its mouse homologue, polycystic kidney disease gene tg737, are required for assembly of cilia and flagella.

Authors:  G J Pazour; B L Dickert; Y Vucica; E S Seeley; J L Rosenbaum; G B Witman; D G Cole
Journal:  J Cell Biol       Date:  2000-10-30       Impact factor: 10.539

View more
  136 in total

1.  Transcriptional analysis of pluripotency reveals the Hippo pathway as a barrier to reprogramming.

Authors:  Han Qin; Kathryn Blaschke; Grace Wei; Yuki Ohi; Laure Blouin; Zhongxia Qi; Jingwei Yu; Ru-Fang Yeh; Matthias Hebrok; Miguel Ramalho-Santos
Journal:  Hum Mol Genet       Date:  2012-01-27       Impact factor: 6.150

2.  Regulation and function of the TAZ transcription co-activator.

Authors:  Chenying Liu; Wei Huang; Qunying Lei
Journal:  Int J Biochem Mol Biol       Date:  2011-07-20

3.  The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase.

Authors:  Chen-Ying Liu; Zheng-Yu Zha; Xin Zhou; Heng Zhang; Wei Huang; Di Zhao; Tingting Li; Siew Wee Chan; Chun Jye Lim; Wanjin Hong; Shimin Zhao; Yue Xiong; Qun-Ying Lei; Kun-Liang Guan
Journal:  J Biol Chem       Date:  2010-09-21       Impact factor: 5.157

4.  Hippo signaling at a glance.

Authors:  Bin Zhao; Li Li; Kun-Liang Guan
Journal:  J Cell Sci       Date:  2010-12-01       Impact factor: 5.285

5.  PP1 cooperates with ASPP2 to dephosphorylate and activate TAZ.

Authors:  Chen-Ying Liu; Xianbo Lv; Tingting Li; Yanping Xu; Xin Zhou; Shimin Zhao; Yue Xiong; Qun-Ying Lei; Kun-Liang Guan
Journal:  J Biol Chem       Date:  2010-12-28       Impact factor: 5.157

Review 6.  Gone Caving: Roles of the Transcriptional Regulators YAP and TAZ in Skeletal Development.

Authors:  Christopher D Kegelman; Joseph M Collins; Madhura P Nijsure; Emily A Eastburn; Joel D Boerckel
Journal:  Curr Osteoporos Rep       Date:  2020-10       Impact factor: 5.096

7.  YAP1 is involved in replenishment of granule cell precursors following injury to the neonatal cerebellum.

Authors:  Zhaohui Yang; Alexandra L Joyner
Journal:  Dev Biol       Date:  2019-07-31       Impact factor: 3.582

8.  EGF Receptor-Dependent YAP Activation Is Important for Renal Recovery from AKI.

Authors:  Jianchun Chen; Huaizhou You; Yan Li; You Xu; Qian He; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2018-08-02       Impact factor: 10.121

Review 9.  The Hippo-YAP pathway: new connections between regulation of organ size and cancer.

Authors:  Bin Zhao; Qun-Ying Lei; Kun-Liang Guan
Journal:  Curr Opin Cell Biol       Date:  2008-11-18       Impact factor: 8.382

10.  Long noncoding RNA Bmncr regulates mesenchymal stem cell fate during skeletal aging.

Authors:  Chang-Jun Li; Ye Xiao; Mi Yang; Tian Su; Xi Sun; Qi Guo; Yan Huang; Xiang-Hang Luo
Journal:  J Clin Invest       Date:  2018-10-22       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.